title: Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation.
abstract: The mitochondrial matrix is unique in that it must integrate the folding and assembly of proteins derived from the nuclear and mitochondrial genomes. In Caenorhabditis elegans, the mitochondrial unfolded protein response (UPRmt) senses matrix protein misfolding and induces a program of nuclear gene expression, including mitochondrial chaperonins, to promote mitochondrial proteostasis. While misfolded mitochondrial-matrix-localized ornithine transcarbamylase induces chaperonin expression, our understanding of mammalian UPRmt is rudimentary, reflecting a lack of acute triggers for UPRmt activation. This limitation has prevented analysis of the cellular responses to matrix protein misfolding and the effects of UPRmt on mitochondrial translation to control protein folding loads. Here we combine pharmacological inhibitors of matrix-localized HSP90/TRAP1 (ref. 8) or LON protease, which promote chaperonin expression, with global transcriptional and proteomic analysis to reveal an extensive and acute response of human cells to UPRmt. This response encompasses widespread induction of nuclear genes, including matrix-localized proteins involved in folding, pre-RNA processing and translation. Functional studies revealed rapid but reversible translation inhibition in mitochondria occurring concurrently with defects in pre-RNA processing caused by transcriptional repression and LON-dependent turnover of the mitochondrial pre-RNA processing nuclease MRPP3 (ref. 10). This study reveals that acute mitochondrial protein folding stress activates both increased chaperone availability within the matrix and reduced matrix-localized protein synthesis through translational inhibition, and provides a framework for further dissection of mammalian UPRmt.
authors.forename: Christian
authors.initials: C
authors.lastname: Münch
authors.forename: J Wade
authors.initials: JW
authors.lastname: Harper
mesh_terms: D002467:Cell Nucleus / Q000235:genetics; D018833:Chaperonins / Q000378:metabolism; D015536:Down-Regulation; D006801:Humans; D008928:Mitochondria / Q000187:drug effects / Q000235:genetics* / Q000378:metabolism*; D024101:Mitochondrial Proteins / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D009954:Ornithine Carbamoyltransferase / Q000378:metabolism; D014176:Protein Biosynthesis / Q000187:drug effects; D017510:Protein Folding; D020543:Proteome / Q000096:biosynthesis / Q000235:genetics / Q000378:metabolism; D012322:RNA Precursors / Q000235:genetics* / Q000378:metabolism*; D012323:RNA Processing, Post-Transcriptional; D012333:RNA, Messenger / Q000235:genetics / Q000378:metabolism; D043262:Ribonuclease P / Q000378:metabolism; D056811:Unfolded Protein Response / Q000187:drug effects / Q000235:genetics
chemical_list: D024101:Mitochondrial Proteins; D020543:Proteome; D012322:RNA Precursors; D012333:RNA, Messenger; D009954:Ornithine Carbamoyltransferase; C545252:PRORP protein, human; D043262:Ribonuclease P; D018833:Chaperonins